Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.56 |
| ▸ | GABRD | O14764 | 2/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.56 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.56 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.56 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.56 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.56 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.56 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.56 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.56 |
| ▸ | GABRE | P78334 | 2/20 | 0.56 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.56 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.56 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.56 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | GRM8 | O00222 | 1/20 | 0.56 |
| ▸ | GRM6 | O15303 | 1/20 | 0.56 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4948196 | 1.00 | GABRP (0.56) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL7286437 | 1.00 | GABRP (0.56) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Hydrochloric Acid SCHEMBL8758700 | 0.98 | GABRP (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Hydrochloric Acid SCHEMBL8758697 | 0.98 | GABRP (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Phosphoric Acid SCHEMBL28734773 | 0.93 | GABRP (0.48) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Sulfuric Acid SCHEMBL28734778 | 0.93 | GABRP (0.48) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL8759171 | 0.91 | GABRP (0.47) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Trifluoroacetic Acid SCHEMBL29511222 | 0.89 | GABRP (0.46) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1300542 | 0.88 | NOD1 (0.47) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL10682747 | 0.86 | ALDH1A1 (0.53) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636476-B2 | Method of implantation of cell aggregates and tissue fragments | NEURONANO AB (SE) | 2026-05-26 | — | — | US | claimed |
| US-20250367111-A1 | DELIVERY OF SUSTAINED LOCAL AND SYSTEMIC IMMUNOMODULATION | UNIV NORTHEASTERN (US) | 2025-12-04 | — | — | US | claimed |
| EP-3452124-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-10-08 | — | — | EP | claimed |
| EP-3452123-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-09-24 | — | — | EP | claimed |
| EP-3452126-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-08-27 | — | — | EP | claimed |
| EP-3452125-B1 | CUSTOMIZABLE ANCHORAGE DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-07-16 | — | — | EP | claimed |
| WO-2025097044-A1 | AEROGEL IMPLANTS FOR CONTRACEPTION | Contraline, Inc. (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025050106-A1 | SUSTAINED RELEASE OCULAR IMPLANTS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2025-03-06 | — | — | WO | claimed |
| CN-119470406-A | Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof | 山东新华莎罗雅生物技术有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118680883-A | Loadable porous structure for use as an implant | 瑞艾克斯制药公司 | 2024-09-24 | — | — | CN | claimed |
| EP-0746270-A1 | DEVICE FOR ORBITAL IMPLANT | ORBITAL IMPLANT TECHNOLOGY (US) | 1996-12-11 | — | — | EP | claimed |
| EP-0705094-A4 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | AMINCO INC (US) | 1996-08-07 | — | — | EP | claimed |
| EP-0705094-A1 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | CARSON PRODUCTS COMPANY (US) | 1996-04-10 | — | — | EP | claimed |
| EP-0662824-A1 | ARTICLE CONTAINING A CORE AND A COATING HAVING A NON CONSTANT THICKNESS | PFIZER INC. (US) | 1995-07-19 | — | — | EP | claimed |
| WO-1995000107-A1 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | AMINCO, INC. (US) | 1995-01-05 | — | — | WO | claimed |
| WO-1994014390-A1 | DEVICE FOR ORBITAL IMPLANT | ORBITAL IMPLANT TECHNOLOGY (US) | 1994-07-07 | — | — | WO | claimed |
| WO-1994007470-A1 | ARTICLE CONTAINING A CORE AND A COATING HAVING A NON CONSTANT THICKNESS | PFIZER INC. (US) | 1994-04-14 | — | — | WO | claimed |
| EP-0527851-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-02-24 | — | — | EP | claimed |
| WO-1991017148-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-11-14 | — | — | WO | claimed |
| US-3936469-A | Process for preparing N-carboxylic anhydrides of amino acids | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12636476-B2 | Method of implantation of cell aggregates and tissue fragments | ILK, CD44, CAPG | GABRP 995/4885GABRD 3320/4885GABRA1 3840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.